1.
Cambio de grosor macular central con la administración de Bevacizumab Intravítreo. Rev. Fac. Med. [Internet]. 2017 Jul. 3 [cited 2025 Oct. 17];1(23). Available from: https://revista-medicina.ufm.edu/index.php/revista/article/view/31